Latest Supply Chain Management News

RooLife Group has secured a two-year supply agreement with Eternal Asia, granting access to over one million retail outlets across China and potential annual orders worth up to AUD 110 million.

Jupiter Mines reports record FY2025 manganese sales and production at Tshipi mine, while Q4 earnings dip due to lower prices and higher costs. Exxaro’s planned majority acquisition signals a new chapter for the asset.

DroneShield Limited has reported a record-breaking second quarter with revenues surging 480% year-on-year, underpinned by a robust $176 million in committed sales and a $2.3 billion pipeline. The company is aggressively expanding manufacturing and investing in next-generation counter-drone technologies to meet soaring global demand.

Spacetalk Ltd reports robust growth in paid mobile subscribers and recurring revenue for Q4 FY25, supported by strategic capital raises and international expansion.

Meteoric Resources has successfully raised $42.5 million through an oversubscribed placement, underpinning its push towards a Final Investment Decision for the Caldeira Rare Earth Project in 2026.

Australian Vintage Ltd is accelerating its inventory reduction by exiting the Millewa Vineyard lease early, unlocking over $8 million in net cash flow benefits and reshaping its grape sourcing strategy.

Ionic Rare Earths is broadening its Viridion Joint Venture to include a US-based rare earth refinery, aiming to strengthen a secure supply chain for critical magnet and heavy rare earth oxides outside China.

BPH Global Ltd has completed its second seaweed sale under a strategic partnership in Indonesia, marking steady progress in its supply network expansion and operational execution.

Brisbane Broncos Limited revealed solid financial results and operational growth for 2024 at their 2025 Annual General Meeting, highlighting record membership and commercial gains alongside strategic investments.

Baby Bunting has reported a robust first half of FY25 with a 37% rise in pro forma NPAT and solid sales growth, underpinned by strategic execution and margin expansion.

Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.